P00720 (ENLYS_BPT4) Enterobacteria phage T4 (Bacteriophage T4)
Endolysin UniProtKBAFDB90v4InterProInteractive Modelling
164 aa; Sequence (Fasta)
Models are currently being built for this target protein.
(Depending on server load, it will take approximately 15-30 minutes before the new models are available in SWISS-MODEL Repository)
Please note that SMR updates are performed with default parameters for template selection and quality filters. If you prefer to interactively explore various models build on different templates, please use SWISS-MODEL workspace.
Available Structures
753 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Application of anti-helix antibodies in protein structure determination (9213-3LRH) |
Heteromer | |||||
Assess | ||||||
Crystal structure of SIV Vpr,fused to T4 lysozyme, isolated from moustached monkey, bound to human … |
Heteromer A4UDG5; Q16531; Q9Y4B6; | 8×GOL; 1×ZN; | ||||
Assess | ||||||
Structure of a cytoplasmic 11-subunit RNA exosome complex including Ski7, bound to RNA |
Heteromer P25359; P38792; P46948; P48240; P53256; P53859; Q05636; Q08162; Q08285; Q08491; Q12277; | 7×MPD; 4×NA; 1×ZN; | ||||
Assess | ||||||
Complex of SpaO(SPOA1,2) and OrgB(APAR)::T4lysozyme fusion protein |
Heteromer P0CL45; P40699; | |||||
Assess | ||||||
Complex of SpaO(SPOA1,2 SeMet) and OrgB(APAR)::T4lysozyme fusion protein |
Heteromer P0CL45; P40699; | |||||
Assess | ||||||
crystal structure of mitochondrial calcium uptake 2(MICU2) |
Heteromer Q8IYU8; | 3×CA; | ||||
Assess | ||||||
Structure of the 2TEL crystallization module fused to T4 lysozyme with a helical linker. |
Heteromer P41212; | 2×NO3; 1×NH4; | ||||
Assess | ||||||
Structure of the 2TEL crystallization module fused to T4 lysozyme with an Ala-Gly-Pro linker. |
Heteromer P41212; | 2×MN; | ||||
Assess | ||||||
The crystal structure of an engineered phage lysin containing the binding domain of pesticin and th… |
Heteromer Q57159; | |||||
Assess | ||||||
Crystal structure of human claudin-4 in complex with C-terminal fragment of Clostridium perfringens… |
Heteromer O14493; P01558; | |||||
Assess | ||||||
Complex of FliM(SPOA)::FliN fusion protein and FliH(APAR)::T4lysozyme fusion protein |
Heteromer P26418; P26419; | |||||
Assess | ||||||
Structure of active-like neurotensin receptor |
Heteromer P20068; P20789; | 1×CIT; 5×PEG; 3×GOL; 2×EPE; | ||||
Assess | ||||||
Structure of beta2 adrenoceptor bound to BI167107 and an engineered nanobody |
Heteromer P07550; | 1×P0G; 1×NA; 1×1WV; | ||||
Assess | ||||||
Human endothelin receptor type-B in complex with ET-1 |
Heteromer P05305; P24530; | |||||
Assess | ||||||
Crystal structure of the KAP1 tripartite motif in complex with the ZNF93 KRAB domain |
Heteromer P35789; Q13263; Q9H4L7; | 8×ZN; | ||||
Assess | ||||||
The crystal structure of the neurotensin receptor NTS1 in complex with neurotensin (8-13) |
Heteromer P20068; P20789; | 2×EPE; | ||||
Assess | ||||||
Structure of active-like neurotensin receptor |
Heteromer P20068; P20789; | 2×1PE; 1×EPE; 1×FLC; 1×PEG; | ||||
Assess | ||||||
Crystal structure of human beta2 adrenergic receptor bound to salmeterol and Nb71 |
Heteromer P07550; | 1×K5Y; 1×MG; 3×NI; 1×OLC; 1×HTO; 1×OLA; 1×P33; | ||||
Assess | ||||||
Structure of the glucagon receptor in complex with a glucagon analogue |
Heteromer P01275; P47871; | 2×NAG; 6×OLC; 1×PO4; | ||||
Assess | ||||||
Structure of the Full-length glucagon class B G protein-coupled receptor |
Heteromer P47871; | 3×NAG; 1×NAG; 1×97V; | ||||
Assess | ||||||
Crystal structure of the chemokine CXCR4 receptor in complex with a small molecule antagonist IT1t … |
Heteromer P61073; | 2×ITD; | ||||
Assess | ||||||
Crystal structure of CXCR4 and viral chemokine antagonist vMIP-II complex (PSI Community Target) |
Heteromer P61073; Q98157; | |||||
Assess | ||||||
Structure of beta2 adrenoceptor bound to hydroxybenzylisoproterenol and an engineered nanobody |
Heteromer P07550; | 1×XQC; 1×NA; 1×1WV; | ||||
Assess | ||||||
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t … |
Heteromer P61073; | 2×ITD; | ||||
Assess | ||||||
Structure of the Full-length glucagon class B G protein-coupled receptor |
Heteromer P47871; | 3×NAG; 1×97V; | ||||
Assess | ||||||
Crystal structure of the beta2 adrenergic receptor-Gs protein complex |
Heteromer P04896; P07550; P54311; P63212; | 1×P0G; | ||||
Assess | ||||||
Structure of beta2 adrenoceptor bound to carazolol and inactive-state stabilizing nanobody, Nb60 |
Heteromer P07550; | 1×CAU; 1×CLR; | ||||
Assess | ||||||
Structure of beta2 adrenoceptor bound to adrenaline and an engineered nanobody |
Heteromer P07550; | 1×1WV; 1×ALE; 2×NA; | ||||
Assess | ||||||
STRUCTURE OF CONSTITUTIVELY ACTIVE NEUROTENSIN RECEPTOR |
Heteromer P20068; P20789; | 1×TCE; 1×GOL; 3×PEG; | ||||
Assess | ||||||
Structure of beta2 adrenoceptor bound to a covalent agonist and an engineered nanobody |
Heteromer P07550; | 2×NA; 1×35V; | ||||
Assess | ||||||
N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor |
Heteromer P07550; | 1×CAU; | ||||
Assess | ||||||
Crystal structure of the human platelet-activating factor receptor in complex with ABT-491 |
Heteromer P25105; | 2×9EU; 7×OLC; 2×ZN; 6×SO4; | ||||
Assess | ||||||
Zn-mediated Hexamer of T4 Lysozyme R76H/R80H by Synthetic Symmetrization | homo-6-mer | 3×ZN; 1×CL; | ||||
Assess | ||||||
Disulphide-mediated Tetramer of T4 Lysozyme R76C/R80C by Synthetic Symmetrization | homo-4-mer | 12×CL; | ||||
Assess | ||||||
Zn-mediated Trimer of T4 Lysozyme R125C/E128C by Synthetic Symmetrization | homo-3-mer | 6×ZN; 6×CL; 6×MG; 6×GOL; | ||||
Assess | ||||||
Cu-mediated Trimer of T4 Lysozyme D61H/K65H/R76H/R80H by Synthetic Symmetrization | homo-3-mer | 3×CU; | ||||
Assess | ||||||
Crystal structure of T4 Lysozyme S44C synthetic dimer | homo-2-mer | 8×SO4; 6×GOL; | ||||
Assess | ||||||
Crystal structure of T4 Lysozyme V131C synthetic dimer | homo-2-mer | 8×SO4; | ||||
Assess | ||||||
Crystal structure of T4 Lysozyme D72C synthetic dimer | homo-2-mer | 1×TRS; | ||||
Assess | ||||||
Structure of the BBox-Coiled-coil region of Rhesus Trim5alpha | homo-2-mer | 4×ZN; | ||||
Assess | ||||||
Crystal Structure of T4 lysozyme with the unnatural amino acid p-Acetyl-L-Phenylalanine incorporate… | homo-2-mer | 4×AZI; 6×CL; | ||||
Assess | ||||||
Wild type T4 lysozyme structure | homo-2-mer | 4×SO4; 2×EPE; 3×CL; 3×GOL; | ||||
Assess | ||||||
Cu-mediated Dimer of T4 Lysozyme R76H/R80H by Synthetic Symmetrization | homo-2-mer | 2×FMT; 1×CU; | ||||
Assess | ||||||
Cu-mediated Dimer of T4 Lysozyme D61H/K65H by Synthetic Symmetrization | homo-2-mer | 2×CU; | ||||
Assess | ||||||
Cu-mediated Dimer of T4 Lysozyme D61H/K65H/R76H/R80H by Synthetic Symmetrization | homo-2-mer | 2×CU; 2×CL; | ||||
Assess | ||||||
The crystal structure of pesticin-T4 lysozyme hybrid stabilized by engineered disulfide bonds | homo-2-mer | 2×SO4; 8×NA; | ||||
Assess | ||||||
The 2.5 A structure of the CXCR4 chemokine receptor in complex with small molecule antagonist IT1t | homo-2-mer | 2×ITD; 5×OLC; 6×OLA; | ||||
Assess | ||||||
Crystal structure of the mu-opioid receptor bound to a morphinan antagonist | homo-2-mer | 2×BF0; 24×SO4; 2×CLR; 4×MPG; 2×1PE; 2×CL; | ||||
Assess | ||||||
Structure of the human kappa opioid receptor in complex with JDTic | homo-2-mer | 2×JDC; 1×CIT; 2×OLC; 2×PEG; | ||||
Assess | ||||||
Crystal structure of the CXCR4 chemokine receptor in complex with a cyclic peptide antagonist CVX15 | homo-2-mer | |||||
Assess | ||||||
Crystal Structure of Saccharomyces cerevisiae Upc2 Transcription Factor fused with T4 Lysozyme | homo-2-mer | |||||
Assess | ||||||
Structure of the tripartite motif of KAP1/TRIM28 | homo-2-mer | 8×ZN; | ||||
Assess | ||||||
Crystal structure of the CXCR4 chemokine receptor in complex with a small molecule antagonist IT1t … | homo-2-mer | 2×ITD; 6×OLC; 2×GOL; | ||||
Assess | ||||||
Structure of the ligand-binding domain of S. cerevisiae Upc2 in fusion with T4 lysozyme | homo-2-mer | |||||
Assess | ||||||
Crystal structure of rhodopsin bound to visual arrestin | homo-2-mer | |||||
Assess | ||||||
T4 lysozyme C-terminal fragment | monomer | 1×ACT; 1×CL; | ||||
Assess | ||||||
Structure of Spin-labelled T4 lysozyme mutant L118C-R1 at 100K | monomer | 1×MTN; 3×CL; 1×BME; 2×AZI; 1×K; | ||||
Assess | ||||||
High-resolution X-ray structure of the T26H mutant of T4 lysozyme | monomer | 3×NA; 5×CL; 4×HEZ; 3×GOL; | ||||
Assess | ||||||
Structure of (3S,4S)-1-benzyl-4-(3-(3-(trifluoromethyl)phenyl)ureido)piperidin-3-yl acetate bound t… | monomer | 1×DOJ; | ||||
Assess | ||||||
Use of a Halide Binding Site to Bypass the 1000-atom Limit to Structure Determination by Direct Met… | monomer | 5×RB; 5×CL; 2×BME; | ||||
Assess | ||||||
Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure determination by di… | monomer | 1×PO4; 5×RB; 4×CL; 2×BME; | ||||
Assess | ||||||
Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure determination by di… | monomer | 5×RB; 4×CL; 2×BME; | ||||
Assess | ||||||
Use of a Halide Binding Site to Bypass the 1000-atom Limit to Ab initio Structure Determination | monomer | 5×RB; 5×CL; 2×BME; | ||||
Assess | ||||||
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T… | monomer | 1×HED; 1×PO4; 2×CL; 1×NA; 1×K; | ||||
Assess | ||||||
Structure of 1-(benzo[d][1,3]dioxol-5-ylmethyl)-1-(1-propylpiperidin-4-yl)-3-(3-(trifluoromethyl)ph… | monomer | 1×DQD; | ||||
Assess | ||||||
Structure of Spin-labelled T4 lysozyme mutant L115C-R119C-R1 at 100K | monomer | 1×RXR; 4×CL; 1×HED; 1×PO4; 1×BME; 2×K; | ||||
Assess | ||||||
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T… | monomer | 2×PO4; 1×BME; | ||||
Assess | ||||||
New azaborine compounds bind to the T4 lysozyme L99A cavity - 1,2-dihydro-1,2-azaborine | monomer | 2×HED; 1×PO4; 1×NA; 1×B20; | ||||
Assess | ||||||
New azaborine compounds bind to the T4 lysozyme L99A cavity - Benzene as control | monomer | 2×HED; 1×PO4; 1×BNZ; | ||||
Assess | ||||||
New azaborine compounds bind to the T4 lysozyme L99A cavity - 1-ethyl-2-hydro-1,2-azaborine | monomer | 1×HED; 1×NA; 1×PO4; 1×B24; | ||||
Assess | ||||||
Polar and non-polar cavities in phage T4 lysozyme | monomer | 1×K; 2×CL; 1×AZI; 1×EPE; 2×BME; 2×HED; 2×GOL; | ||||
Assess | ||||||
T4 Lysozyme L99A - 4-iodotoluene - cryo | monomer | 1×TRS; 1×BME; 1×CA; 1×XQM; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 2-Mercaptoethanol Bound | monomer | 5×BME; 3×SO4; 1×HED; | ||||
Assess | ||||||
Structure of DCN1 bound to NAcM-OPT | monomer | 1×8ZA; | ||||
Assess | ||||||
T4 Lysozyme L99A with n-Hexylbenzene Bound | monomer | 1×3GZ; 1×EPE; | ||||
Assess | ||||||
Structure of Spin labeled T4 Lysozyme Mutant T115R1A | monomer | 1×MTN; | ||||
Assess | ||||||
New strategy to analyze structures of glycopeptide antibiotic-target complexes | monomer | 1×BGC; 1×MPD; 2×MRD; 1×PO4; 1×TRS; 1×CL; 2×IPA; | ||||
Assess | ||||||
Structure of Spin-labeled T4 Lysozyme Mutant T115R7 | monomer | 1×R7A; 1×BME; | ||||
Assess | ||||||
High resolution crystal structure of T4 lysozyme mutant L20R63/A liganded to guanidinium ion | monomer | 1×CL; 1×GAI; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A with No Ligand Bound | monomer | 1×EPE; | ||||
Assess | ||||||
T4 LYOSZYME CORE REPACKING MUTANT I100V/TA | monomer | 1×K; 2×CL; 1×BME; | ||||
Assess | ||||||
Multiple methionine substitutions are tolerated in T4 lysozyme and have coupled effects on folding … | monomer | 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
Spin-Labeled T4 Lysozyme Construct K43V1 | monomer | 1×V1A; 3×CL; 1×PO4; 1×K; 1×HEZ; | ||||
Assess | ||||||
Spin-Labeled T4 Lysozyme Construct R119V1 | monomer | 1×PO4; 3×CL; 1×K; 1×V1A; | ||||
Assess | ||||||
Spin-Labeled T4 Lysozyme Construct I9V1/V131V1 (30 days) | monomer | 2×V1A; 1×HEZ; 3×CL; 1×K; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 2-allylphenol bound | monomer | 2×BME; 1×2LP; 2×SO4; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 2-Cyanophenol Bound | monomer | 2×BME; 2×0R0; 2×SO4; 1×ACT; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING MUTANT V103I/TA | monomer | |||||
Assess | ||||||
T4 Lysozyme L99A with Benzene Bound | monomer | 1×BNZ; 1×EPE; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with phenol bound | monomer | 3×BME; 1×IPH; 3×SO4; 2×ACT; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme Core Repacking Mutant V149I/T152V/TA | monomer | 1×PO4; 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 2-(pyrazolo-1-yl) ethanol bound | monomer | 3×BME; 1×1DU; 4×SO4; 1×ACT; 1×HED; | ||||
Assess | ||||||
Crystal Structure of T4 Lysozyme Mutant R96W | monomer | 1×CL; 1×NA; 1×IPA; | ||||
Assess | ||||||
Spin-Labeled T4 Lysozyme Construct V131V1 | monomer | 3×CL; 1×K; 1×V1A; 1×PO4; | ||||
Assess | ||||||
Spin-Labeled T4 Lysozyme Construct I9V1 | monomer | 4×CL; 1×K; 1×V1A; 1×PO4; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 4-Nitrophenol Bound | monomer | 1×BME; 2×NPO; 3×SO4; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING MUTANT M120Y/TA | monomer | 1×PO4; 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 2-bromo-5-hydroxybenzaldehyde bound | monomer | 2×BME; 1×1DW; 3×SO4; 1×ACT; 1×HED; | ||||
Assess | ||||||
CORE REDESIGN BACK-REVERTANT I103V/CORE10 | monomer | 1×PO4; 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
Structure of Spin-labeled T4 Lysozyme Mutant T115R1/R119A | monomer | 1×MTN; | ||||
Assess | ||||||
T4 Lysozyme L99A with Toluene Bound | monomer | 1×MBN; 1×EPE; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING MUTANT I118L/CORE7/TA | monomer | 1×K; 2×CL; 1×BME; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING BACK-REVERTANT L102M/CORE10 | monomer | 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING MUTANT I78V/TA | monomer | 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 1-phenyl-2-propyn-1-ol bound | monomer | 3×BME; 1×1DJ; 4×SO4; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 4-trifluoromethylimidazole bound | monomer | 3×BME; 1×1DQ; 6×SO4; 1×ACT; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme Core Repacking Mutant V87I/TA | monomer | 1×PO4; 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (V131R1F) | monomer | 1×R1F; 4×CL; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 4-bromoimidazole bound | monomer | 2×BME; 1×ES3; 6×SO4; 1×HED; | ||||
Assess | ||||||
Structure of DCN1 bound to NAcM-COV | monomer | 1×8ZD; | ||||
Assess | ||||||
Structure of Spin-labelled T4 lysozyme mutant L118C-R1 at Room Temperature | monomer | 1×MTN; 1×HED; 1×CL; 1×NA; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING MUTANT L133F/TA | monomer | 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A with sec-Butylbenzene Bound | monomer | 1×3GY; 1×EPE; | ||||
Assess | ||||||
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
X-ray structure of perdeuterated T4 lysozyme cysteine-free pseudo-wild type at cryogenic temperature | monomer | 1×PO4; 1×NA; 1×HED; 2×CL; 1×GOL; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with Nitrobenzene Bound | monomer | 2×BME; 1×NBZ; 3×SO4; 2×ACT; | ||||
Assess | ||||||
Contribution of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme | monomer | 1×K; 2×CL; 1×BME; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with Isoxazole Bound | monomer | 2×BME; 1×0R1; 3×SO4; 2×ACT; | ||||
Assess | ||||||
T4 Lysozyme L99A with n-Propylbenzene Bound | monomer | 1×3H0; 1×EPE; | ||||
Assess | ||||||
Free of ligand binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 1×PO4; 1×CL; 3×HED; 1×BME; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 1×BME; | ||||
Assess | ||||||
T4 Lysozyme Core Repacking Mutant L118I/TA | monomer | 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING MUTANT CORE10/TA | monomer | 1×K; 2×CL; 1×BME; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with benzene bound | monomer | 4×BME; 1×BNZ; 3×SO4; 1×ACT; 1×HED; | ||||
Assess | ||||||
T4 lysozyme mutant D89A/R96H at room temperature | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T4 lysozyme core repacking mutant M106I/TA | monomer | 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme | monomer | 2×CL; 1×K; 1×BME; | ||||
Assess | ||||||
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme | monomer | 2×CL; 1×K; 1×BME; | ||||
Assess | ||||||
Bacteriophage lysozyme T4 lysozyme mutant K85A/R96H | monomer | 1×CL; 1×BME; | ||||
Assess | ||||||
T4 Lysozyme L99A with n-Butylbenzene Bound | monomer | 1×N4B; 1×EPE; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 3-trifluoromethyl-5-methyl pyrazole bound | monomer | 1×BME; 1×1DV; 4×SO4; 1×ACT; 1×HED; | ||||
Assess | ||||||
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-… | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | 1×BME; | ||||
Assess | ||||||
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ… | monomer | 1×BME; | ||||
Assess | ||||||
ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLES | monomer | |||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LY… | monomer | |||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDING | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LY… | monomer | |||||
Assess | ||||||
STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT… | monomer | |||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | |||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDING | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3 | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-… | monomer | |||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (V131R7) | monomer | 1×R7A; 1×AZI; 3×CL; 1×HED; | ||||
Assess | ||||||
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ… | monomer | |||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | 1×BME; | ||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
STRUCTURAL ANALYSIS OF THE TEMPERATURE-SENSITIVE MUTANT OF BACTERIOPHAGE T4 LYSOZYME, GLYCINE 156 (… | monomer | |||||
Assess | ||||||
STRUCTURAL STUDIES OF MUTANTS OF T4 LYSOZYME THAT ALTER HYDROPHOBIC STABILIZATION | monomer | |||||
Assess | ||||||
STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME REFINED AT 1.7 ANGSTROMS RESOLUTION | monomer | |||||
Assess | ||||||
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-… | monomer | |||||
Assess | ||||||
STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT… | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | 1×BME; | ||||
Assess | ||||||
Xray crystal structure of T4 lysozyme mutant L20/R63A liganded to methylguanidinium | monomer | 1×CL; 1×MGX; 1×BME; | ||||
Assess | ||||||
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-… | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3 | monomer | |||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
R96Q Mutant of wildtype phage T4 lysozyme at 298 K | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 1,2-Azaborine bound | monomer | 1×B20; 2×SO4; 1×BME; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with toluene bound | monomer | 2×BME; 1×MBN; 3×SO4; 1×ACT; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102H with 2-amino-5-chlorothiazole bound | monomer | 3×BME; 1×1DH; 5×SO4; 1×HED; | ||||
Assess | ||||||
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (V131R1) | monomer | 1×MTN; 1×AZI; 3×CL; 1×HED; | ||||
Assess | ||||||
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE… | monomer | |||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T4 Lysozyme L99A with Ethylbenzene Bound | monomer | 1×PYJ; 1×EPE; | ||||
Assess | ||||||
T4 Lysozyme L99A with n-Pentylbenzene Bound | monomer | 1×3H2; 1×EPE; | ||||
Assess | ||||||
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE… | monomer | |||||
Assess | ||||||
1,3,5-trifluoro-2,4,6-trichlorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×F3B; 2×HED; | ||||
Assess | ||||||
Pentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×CL; 1×F5B; 2×HED; | ||||
Assess | ||||||
E11N Mutant of T4 Lysozyme | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-… | monomer | |||||
Assess | ||||||
Xray crystal structure of lysozyme mutant L20/R63A liganded to ethylguanidinium | monomer | 1×BME; 1×EGD; | ||||
Assess | ||||||
D20E MUTANT STRUCTURE OF T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
Structure of Spin-labeled T4 Lysozyme Mutant L118R1 | monomer | 1×MTN; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149G | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
Iodobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×PIH; 3×HED; | ||||
Assess | ||||||
CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-… | monomer | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149I | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTU… | monomer | 1×BME; | ||||
Assess | ||||||
Crystal Structure of Spin Labeled T4 Lysozyme Mutant 115-119RX | monomer | 1×RXR; 1×AZI; 2×CL; 1×HED; 1×BME; | ||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (V131R1B) | monomer | 1×R1B; 2×AZI; 3×CL; 1×HED; | ||||
Assess | ||||||
Bromopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×BBF; 2×HED; | ||||
Assess | ||||||
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ… | monomer | |||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | |||||
Assess | ||||||
Chloropentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×CL; 1×BCF; 2×HED; | ||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152V | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
Contributions of all 20 amino acids at site 96 to stability and structure of T4 lysozyme | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 2×BME; | ||||
Assess | ||||||
Benzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×CL; 2×HED; 1×BNZ; | ||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152S | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
HYDROLASE | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
BACTERIOPHAGE T4 LYSOZYME | monomer | |||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
Bacteriophage T4 lysozyme mutant D89A in wildtype background at room temperature | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T26D MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE… | monomer | |||||
Assess | ||||||
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ… | monomer | 1×BME; | ||||
Assess | ||||||
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ… | monomer | |||||
Assess | ||||||
ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLES | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE… | monomer | |||||
Assess | ||||||
Mutant K85A of T4 lysozyme in wildtype background at room temperature | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152C | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149S | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LY… | monomer | |||||
Assess | ||||||
CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRE… | monomer | |||||
Assess | ||||||
T4 Lysozyme S44E/WT* | monomer | 2×BME; | ||||
Assess | ||||||
THE STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF BURYING A CHARGED RESIDUE WITHIN THE HYDROPHOBIC C… | monomer | |||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY | monomer | |||||
Assess | ||||||
E11H Mutant of T4 Lysozyme | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T4 LYSOZYME CORE REPACKING MUTANT A111V/CORE10/TA | monomer | 1×K; 2×CL; 1×HED; | ||||
Assess | ||||||
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTU… | monomer | 1×BME; | ||||
Assess | ||||||
HIGH-RESOLUTION STRUCTURE OF THE TEMPERATURE-SENSITIVE MUTANT OF PHAGE LYSOZYME, ARG 96 (RIGHT ARRO… | monomer | |||||
Assess | ||||||
Alternative Structures of a Sequence Extended T4 Lysozyme Show that the Highly Conserved Beta-Sheet… | monomer | 1×BME; | ||||
Assess | ||||||
STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZ… | monomer | |||||
Assess | ||||||
T26H Mutant of T4 Lysozyme | monomer | 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT M6L | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
LYSOZYME | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | 1×BME; | ||||
Assess | ||||||
T4 lysozyme circular permutant | monomer | 2×CL; | ||||
Assess | ||||||
Mutant R96A OF T4 lysozyme in wildtype background at 298K | monomer | 1×CL; 1×BME; | ||||
Assess | ||||||
PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTU… | monomer | 1×BME; | ||||
Assess | ||||||
D20C MUTANT OF T4 LYSOZYME | monomer | 1×BME; | ||||
Assess | ||||||
STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO | monomer | |||||
Assess | ||||||
Repacking of the Core of T4 Lysozyme by Automated Design | monomer | |||||
Assess | ||||||
USE OF SEQUENCE DUPLICATION TO ENGINEER A LIGAND-TRIGGERED LONG-DISTANCE MOLECULAR SWITCH IN T4 Lys… | monomer | 1×CL; 1×GAI; 1×HED; | ||||
Assess | ||||||
Hexafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×CL; 1×HFB; 2×HED; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4-LYSOZYME GENERATED FROM SYNTHETIC CODING DNA EXPRESSED IN ESCHERICHIA COLI | monomer | |||||
Assess | ||||||
LYSOZYME | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
Structure of DCN1 bound to NAcM-HIT | monomer | 1×8Z7; | ||||
Assess | ||||||
Crystal Structure T4 Lysozyme incorporating an unnatural amino acid p-iodo-L-phenylalanine at posit… | monomer | 3×CL; 2×BME; | ||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (V131R1) at 291 K | monomer | 1×MTN; 1×AZI; 3×CL; 1×HED; | ||||
Assess | ||||||
T26Q MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 1×CL; 1×HED; | ||||
Assess | ||||||
Crystal structure of phage T4 lysozyme mutant Y24A/Y25A/T26A/I27A/C54T/C97A | monomer | 1×BME; | ||||
Assess | ||||||
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | 1×CL; | ||||
Assess | ||||||
T26E APO STRUCTURE OF T4 LYSOZYME | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
Alternative Structures of a Sequence Extended T4 Lysozyme Show that the Highly Conserved Beta-Sheet… | monomer | 1×SO4; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | 1×SO4; | ||||
Assess | ||||||
Crystal structure of phage T4 lysozyme mutant G28A/I29A/G30A/C54T/C97A | monomer | |||||
Assess | ||||||
ENHANCEMENT OF PROTEIN STABILITY BY THE COMBINATION OF POINT MUTATIONS IN T4 LYSOZYME IS ADDITIVE | monomer | |||||
Assess | ||||||
Are Carboxy Terminii of Helices Coded by the Local Sequence or by Tertiary Structure Contacts | monomer | |||||
Assess | ||||||
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
Fusion protein of T4 lysozyme and B4 domain of protein A from staphylococcal aureus with chemical c… | monomer | 1×EYC; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | 1×BME; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
Sequential reorganization of beta-sheet topology by insertion of a single strand | monomer | 2×SO4; | ||||
Assess | ||||||
Solution Structure of a Minor and Transiently Formed State of a T4 Lysozyme Mutant | monomer | |||||
Assess | ||||||
Solution Structure of a Minor and Transiently Formed State of a T4 Lysozyme Mutant | monomer | |||||
Assess | ||||||
Structure of spin-labeled T4 lysozyme mutant A41R1 | monomer | 1×MTN; 1×BME; | ||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (A82R1) | monomer | 1×MTN; 1×AZI; 3×CL; 1×HED; | ||||
Assess | ||||||
Structure of Spin-labeled T4 Lysozyme Mutant T115R1 at Room Temperature | monomer | 1×MTN; 4×BME; | ||||
Assess | ||||||
Neutron crystal structure of T4L L99AE | monomer | 1×CL; | ||||
Assess | ||||||
Neutron structure of the T26H mutant of T4 lysozyme | monomer | 1×NA; 3×CL; | ||||
Assess | ||||||
Neutron crystal structure of wtT4LE | monomer | 1×CL; | ||||
Assess | ||||||
Structure of spin-labeled T4 lysozyme mutant S44R1 | monomer | 1×MTN; 1×HED; | ||||
Assess | ||||||
Neutron crystal structure of wtT4LD | monomer | 1×CL; | ||||
Assess | ||||||
Neutron crystallographic structure of perdeuterated T4 lysozyme cysteine-free pseudo-wild type at c… | monomer | 2×CL; | ||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 1-fluoranylnaphthalene | monomer | 1×Y84; 1×BME; 1×TRS; | ||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 2-butylthiophene | monomer | 1×Y8G; 1×BME; 1×TRS; | ||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 3-fluoroiodobenzene | monomer | 1×Y7V; 3×BME; 1×TRS; | ||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 1-bromanyl-4-fluoranyl-benzene | monomer | 2×BME; 1×TRS; 1×Y87; | ||||
Assess | ||||||
New azaborine compounds bind to the T4 lysozyme L99A cavity -ethylbenzene as control | monomer | 2×HED; 1×PO4; 1×PYJ; | ||||
Assess | ||||||
4,5,6,7-tetrahydroindole in complex with T4 lysozyme L99A/M102Q | monomer | 1×JZ9; 2×BME; 1×PO4; | ||||
Assess | ||||||
(Z)-Thiophene-2-carboxaldoxime in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×JZ5; 2×BME; | ||||
Assess | ||||||
Spin-Labeled T4 Lysozyme Construct T151V1 | monomer | 1×CL; 1×K; 1×V1A; 1×PO4; 2×HEZ; | ||||
Assess | ||||||
Spin-Labeled T4 Lysozyme Construct A73V1 | monomer | 5×CL; 1×K; 1×V1A; 2×HEZ; | ||||
Assess | ||||||
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | monomer | 2×CL; 1×ZN; | ||||
Assess | ||||||
STRUCTURE OF A THERMOSTABLE DISULFIDE-BRIDGE MUTANT OF PHAGE T4 LYSOZYME SHOWS THAT AN ENGINEERED C… | monomer | |||||
Assess | ||||||
2-propylphenol in complex with T4 lysozyme L99A/M102Q | monomer | 2×PO4; 1×JZ4; 1×BME; | ||||
Assess | ||||||
A COVALENT ENZYME-SUBSTRATE INTERMEDIATE WITH SACCHARIDE DISTORTION IN A MUTANT T4 LYSOZYME | monomer | 1×MUB; 1×BME; | ||||
Assess | ||||||
Crystal structure of the phosphatidylinositol 4-kinase IIbeta | monomer | 1×ATP; | ||||
Assess | ||||||
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME | monomer | 1×SO4; | ||||
Assess | ||||||
Structure of the T4Lnano fusion protein | monomer | 5×CA; 5×GOL; 2×CL; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
Crystal structure of phosphatidyl inositol 4-kinase II beta in complex with MM1373 | monomer | 1×L6A; | ||||
Assess | ||||||
Crystal structure of a pesticin (translocation and receptor binding domain) from Y. pestis and T4-l… | monomer | 2×SO4; | ||||
Assess | ||||||
Crystal structure of phosphatidyl inositol 4-kinase II alpha in the apo state | monomer | |||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 1-fluoranyl-4-iodanyl-benzene | monomer | 1×Y8D; 3×BME; 1×TRS; | ||||
Assess | ||||||
T4 lysozyme mutant L99A | monomer | 1×YGV; 1×TRS; | ||||
Assess | ||||||
T4 lysozyme mutant L99A | monomer | 1×YGG; 1×TRS; | ||||
Assess | ||||||
T4 lysozyme mutant L99A | monomer | 1×YGJ; 1×TRS; | ||||
Assess | ||||||
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T… | monomer | 1×HED; 1×BME; 2×PO4; 2×CL; 1×K; | ||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 1-fluoro-2-[(prop-2-en-1-yl)oxy]benzene | monomer | 1×ZNV; 1×BME; 1×TRS; | ||||
Assess | ||||||
T4 Lysozyme L99A - toluene - cryo | monomer | 1×MBN; | ||||
Assess | ||||||
T4 Lysozyme L99A - benzylacetate - cryo | monomer | 1×TRS; 1×BME; 1×CL; 1×J0Z; | ||||
Assess | ||||||
T4 Lysozyme L99A - 3-iodotoluene - cryo | monomer | 1×TRS; 1×BME; 1×CL; 1×XQJ; | ||||
Assess | ||||||
Evaulaution at Atomic Resolution of the Role of Strain in Destabilizing the Temperature Sensitive T… | monomer | 1×PO4; 1×NA; 2×CL; 1×K; | ||||
Assess | ||||||
T4 lysozyme mutant L99A | monomer | 1×YGM; 1×TRS; | ||||
Assess | ||||||
2-ethoxy-3,4-dihydro-2h-pyran in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×BME; 1×JZ7; | ||||
Assess | ||||||
T4 Lysozyme L99A - iodobenzene - RT | monomer | 1×TRS; 2×BME; 1×CL; 1×PIH; | ||||
Assess | ||||||
N-phenylglycinonitrile in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×264; | ||||
Assess | ||||||
Benzylacetate in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×J0Z; 2×BME; | ||||
Assess | ||||||
2-nitrothiophene in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×265; | ||||
Assess | ||||||
T4 Lysozyme L99A - o-xylene - RT | monomer | 1×TRS; 1×CL; 1×BME; 1×OXE; | ||||
Assess | ||||||
T4 Lysozyme L99A - Apo - cryo | monomer | 1×TRS; 2×BME; 1×CL; | ||||
Assess | ||||||
T4 Lysozyme L99A - toluene - RT | monomer | 1×TRS; 1×CL; 1×MBN; 1×BME; | ||||
Assess | ||||||
T4 lysozyme Y18Ymbr | monomer | 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A - 3-iodotoluene - RT | monomer | 1×TRS; 2×BME; 1×CL; 1×XQJ; | ||||
Assess | ||||||
T4 lysozyme Y18Ymcl | monomer | 1×HED; 3×NA; | ||||
Assess | ||||||
T4 Lysozyme L99A - ethylbenzene - RT | monomer | 1×TRS; 1×BME; 1×CL; 1×PYJ; | ||||
Assess | ||||||
2-phenoxyethanol in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×268; | ||||
Assess | ||||||
T4 Lysozyme L99A - Apo - RT | monomer | 1×TRS; 1×CL; 2×BME; | ||||
Assess | ||||||
Thieno[3,2-b]thiophene in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×J1Z; 3×BME; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Apo structure | monomer | 1×BME; 1×CO3; 1×TAM; 1×SO4; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y18F | monomer | 1×HED; | ||||
Assess | ||||||
Nitrosobenzene in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×NBE; | ||||
Assess | ||||||
T4 Lysozyme L99A - propylbenzene - RT | monomer | 1×TRS; 1×CL; 1×3H0; | ||||
Assess | ||||||
3-methylbenzylazide in complex with T4 lysozyme L99A | monomer | 3×PO4; 1×263; | ||||
Assess | ||||||
2-(n-propylthio)ethanol in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×266; | ||||
Assess | ||||||
T4 Lysozyme L99A - benzylacetate - RT | monomer | 1×TRS; 1×BME; 1×CL; 1×J0Z; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
T4 Lysozyme L99A - 4-iodotoluene - RT | monomer | 1×TRS; 1×CL; 1×XQM; | ||||
Assess | ||||||
Crystal Structure of Spin Labeled T4 Lysozyme Mutant K65V1/R76V1 | monomer | 2×V1A; 2×HEZ; 2×CL; 1×K; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--aniline binding | monomer | 2×ANL; 1×CA; 2×CL; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-I | monomer | 1×HED; 2×NA; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--pyridine binding | monomer | 2×0PY; 1×CO3; 1×MG; 2×CL; | ||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 4-(3-phenylpropyl)aniline | monomer | 1×EPE; 1×Y8M; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-METHYL | monomer | 1×HED; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y88F | monomer | 1×HED; | ||||
Assess | ||||||
Catechol in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 1×CAQ; 1×BME; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-BR | monomer | 1×HED; | ||||
Assess | ||||||
(r)(+)-3-chloro-1-phenyl-1-propanol in complex with T4 lysozyme L99A/M102Q | monomer | 2×PO4; 1×269; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y88PHE-METHYL | monomer | 1×HED; 1×PO4; | ||||
Assess | ||||||
2-methylphenol in complex with T4 lysozyme L99A/M102Q | monomer | 2×PO4; 1×JZ0; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Benzene binding | monomer | 1×BNZ; 1×BME; 1×CO3; 1×EPE; 1×SO4; | ||||
Assess | ||||||
5-chloro-2-methylphenol in complex with T4 lysozyme L99A/M102Q | monomer | 2×PO4; 1×JZ2; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-I | monomer | 1×HED; | ||||
Assess | ||||||
3-methylbenzylazide in complex with T4 L99A/M102Q | monomer | 1×PO4; 1×263; | ||||
Assess | ||||||
4-(methylthio)nitrobenzene in complex with T4 lysozyme L99A | monomer | 3×PO4; 1×259; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
PSEUDO T4 LYSOZYME MUTANT - Y18PHE-BR | monomer | 1×HED; | ||||
Assess | ||||||
T4 lysozyme Y18Ymi | monomer | 1×HED; | ||||
Assess | ||||||
Multiple Methionine Substitutions in T4 Lysozyme | monomer | 1×PO4; 1×CL; 1×BME; | ||||
Assess | ||||||
2-ethoxyphenol in complex with T4 lysozyme L99A | monomer | 1×PO4; 2×261; | ||||
Assess | ||||||
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN… | monomer | 3×CL; 2×BME; | ||||
Assess | ||||||
RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKING | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKING | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 1×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
2-ethylphenol in complex with T4 lysozyme L99A/M102Q | monomer | 2×PO4; 1×JZ1; 1×BME; | ||||
Assess | ||||||
Iodopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant (seleno version) | monomer | 1×PO4; 1×CL; 3×HED; 1×BME; 1×IBF; | ||||
Assess | ||||||
Iodobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant (seleno version) | monomer | 1×PO4; 1×CL; 3×HED; 1×BME; 1×PIH; | ||||
Assess | ||||||
Stabilizing Disulfide Bridge Mutant of T4 Lysozyme | monomer | 1×CL; 1×BME; | ||||
Assess | ||||||
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152I | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
Multiple Methionine Substitutions are Tolerated in T4 Lysozyme and have Coupled Effects on Folding … | monomer | 1×PO4; 3×CL; 1×K; 3×HED; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
TOWARD A SIMPLIFICATION OF THE PROTEIN FOLDING PROBLEM: A STABILIZING POLYALANINE ALPHA-HELIX ENGIN… | monomer | 3×CL; 2×BME; | ||||
Assess | ||||||
A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENE | monomer | 2×CL; 2×BME; 1×BNZ; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149C | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 1×CL; 3×BME; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | 2×BME; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×BME; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT M120K | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
L99G MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HEZ; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PHAGE T4 LYSOZYME | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
beta-chlorophenetole in complex with T4 lysozyme L99A | monomer | 1×PO4; 1×258; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ARE CARBOXY TERMINII OF HELICES CODED BY THE LOCAL SEQUENCE OR BY TERTIARY STRUCTURE CONTACTS | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×OXE; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 2×CL; 1×GAI; 2×BME; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT L121M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/Q105M | monomer | 1×CL; 2×BME; | ||||
Assess | ||||||
Specificity of ligand binding in a buried non-polar cavity of t4 lysozyme: linkage of dynamics and … | monomer | 2×CL; 1×HED; 1×PYJ; | ||||
Assess | ||||||
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (T151R1) at 100 K | monomer | 1×MTN; 1×HED; 2×AZI; 3×CL; | ||||
Assess | ||||||
Crystal structure of phage T4 lysozyme mutant L32A/L33A/T34A/C54T/C97A/E108V | monomer | 1×PO4; 2×CL; 1×BME; | ||||
Assess | ||||||
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM ARGON | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 lysozyme with C-terminal extension | monomer | 1×PO4; 3×CL; 1×GOL; | ||||
Assess | ||||||
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
2-ethoxyphenol in complex with T4 lysozyme L99A/M102Q | monomer | 2×PO4; 1×261; | ||||
Assess | ||||||
Iodopentafluorobenzene binding in the hydrophobic cavity of T4 lysozyme L99A mutant | monomer | 2×PO4; 1×IBF; 3×HED; | ||||
Assess | ||||||
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | monomer | 2×CL; 2×NI; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT L118A | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×BNZ; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR… | monomer | 2×CL; 3×BME; | ||||
Assess | ||||||
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR… | monomer | 2×CL; 3×BME; | ||||
Assess | ||||||
COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STR… | monomer | 2×CL; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
Duplication-extension of Helix A of T4 lysozyme | monomer | |||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×PXY; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×DEN; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×I4B; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×IND; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×N4B; | ||||
Assess | ||||||
SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND … | monomer | 2×CL; 1×HED; 1×BZF; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
1,2-dichlorobenzene in complex with T4 Lysozyme L99A | monomer | 3×PO4; 1×BME; 1×YAN; | ||||
Assess | ||||||
2,6-difluorobenzylbromide complex with T4 lysozyme L99A | monomer | 2×PO4; 1×260; | ||||
Assess | ||||||
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 lysozyme mutant L99A/M102Q bound by 3-chlorophenol | monomer | 2×CL; 2×BME; 1×3CH; | ||||
Assess | ||||||
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
4-chloro-1h-pyrazole in complex with T4 lysozyme L99A/M102Q | monomer | 1×PO4; 2×JZ6; 1×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT L84M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Toluene binding | monomer | 1×MBN; 1×CA; 2×CL; | ||||
Assess | ||||||
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T4 Lysozyme Mutant L99A/M102Q Bound by 2-fluoroaniline | monomer | 2×CL; 2×BME; 1×1AN; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT, T21H/C54T/C97A/Q141H/T142H | monomer | 1×SO4; 1×CL; 1×CO; | ||||
Assess | ||||||
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
L99G/E108V MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HEZ; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 2×CL; 2×BME; 1×BNZ; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
STRUCTURAL BASIS OF AMINO ACID ALPHA HELIX PROPENSITY | monomer | |||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 3×CL; 2×BME; | ||||
Assess | ||||||
CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT L133M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
Bacteriophage T4 lysozyme mutant R96V in wildtype background at low temperature | monomer | 1×HEZ; 2×MPD; | ||||
Assess | ||||||
N-TERMINAL DOMAIN CORE METHIONINE MUTATION | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | 2×HED; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | |||||
Assess | ||||||
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENE | monomer | 2×CL; 2×BME; 1×BNZ; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM KRYPTON | monomer | 2×CL; 3×KR; 2×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM KRYPTON | monomer | 2×CL; 2×KR; 2×BME; | ||||
Assess | ||||||
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN… | monomer | 3×CL; 2×BME; | ||||
Assess | ||||||
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
CAVITY CREATING MUTATION | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 4-FluoroPhenEthyl Alcohol | monomer | 2×CL; 3×BME; 1×4FA; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT L118M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN… | monomer | 3×CL; 2×BME; | ||||
Assess | ||||||
TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT V149M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM XENON | monomer | 2×CL; 3×XE; 3×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM KRYPTON | monomer | 2×CL; 1×KR; 2×BME; | ||||
Assess | ||||||
L99A/E108V MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/N101A | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/I58T | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152A | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme Mutant L99A/M102Q | monomer | 2×CL; 3×BME; | ||||
Assess | ||||||
E108V MUTANT OF T4 LYSOZYME | monomer | 1×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme Mutant L99A/M102Q Bound by 3,5-difluoroaniline | monomer | 2×CL; 2×BME; 1×5AN; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 2 ATM XENON | monomer | 1×CL; 3×XE; 2×BME; | ||||
Assess | ||||||
TOLERANCE OF T4 LYSOZYME TO PROLINE SUBSTITUTIONS WITHIN THE LONG INTERDOMAIN ALPHA-HELIX ILLUSTRAT… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 2-Propyl-Aniline | monomer | 2×CL; 2×BME; 1×PRY; | ||||
Assess | ||||||
ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED T… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM ARGON | monomer | 2×CL; 1×AR; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT WITH CYS 54 REPLACED BY THR, CYS 97 REPLACED BY ALA, THR 21 REPLACED BY CYS AND … | monomer | 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM XENON | monomer | 2×CL; 3×XE; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM ARGON | monomer | 2×CL; 3×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT M106L | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 1×CL; 3×BME; 1×BNZ; | ||||
Assess | ||||||
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT M120L | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 1×PXY; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM ARGON | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
BACTERIOPHAGE T4 LYSOZYME MUTANT | monomer | 1×BME; | ||||
Assess | ||||||
AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | monomer | 2×CL; 1×CO; | ||||
Assess | ||||||
1-methylpyrrole in complex with T4 Lysozyme L99A | monomer | 2×PO4; 2×MR3; | ||||
Assess | ||||||
T4 LYSOZYME METHIONINE CORE MUTANT | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme Cavity Mutant L99A/M102Q Bound With 2-Chloro-6-Methyl-Aniline | monomer | 2×CL; 3×BME; 1×2CM; | ||||
Assess | ||||||
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS | monomer | 3×CL; 1×HED; | ||||
Assess | ||||||
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
N-TERMINAL DOMAIN CORE METHIONINE MUTATION | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme mutant R96Y at room temperature | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM KRYPTON | monomer | 2×CL; 1×KR; 2×BME; | ||||
Assess | ||||||
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFEREN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 32 ATM ARGON | monomer | 2×CL; 3×AR; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM ARGON | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
HYDROPHOBIC CORE REPACKING AND AROMATIC-AROMATIC INTERACTION IN THE THERMOSTABLE MUTANT OF T4 LYSOZ… | monomer | 1×PO4; 2×CL; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM ARGON | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme Mutant L99A/M102Q Bound by Phenol | monomer | 2×CL; 1×IPH; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with 2-Allyl-6-Methyl-Phenol | monomer | 2×CL; 1×LYL; 2×BME; | ||||
Assess | ||||||
T4 lysozyme mutant L99A/M102Q bound by 5-methylpyrrole | monomer | 2×CL; 1×5MP; 1×BME; | ||||
Assess | ||||||
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with 3-Fluoro-2-Methyl_Aniline | monomer | 2×CL; 3×BME; 1×FLM; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM XENON | monomer | 2×CL; 1×XE; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM KRYPTON | monomer | 2×CL; 3×KR; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM XENON | monomer | 2×CL; 1×XE; 2×BME; | ||||
Assess | ||||||
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM KRYPTON | monomer | 2×CL; 3×KR; 1×BME; | ||||
Assess | ||||||
A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
METHIONINE CORE MUTATION | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO AC… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 2×BME; | ||||
Assess | ||||||
GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | monomer | 2×CL; 2×BME; 1×BNZ; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 1×CL; 2×BME; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM ARGON | monomer | 2×CL; 2×AR; 2×BME; | ||||
Assess | ||||||
High-pressure structure of pseudo-WT T4 Lysozyme | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
High-pressure structure of pseudo-WT T4 Lysozyme | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME SUBSTITUTED WITH SELENOMETHIONINE | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
2-methoxyphenol in complex with T4 lysozyme L99A/M102Q | monomer | 2×PO4; 1×JZ3; 1×BME; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | |||||
Assess | ||||||
T4 LYSOZYME MUTANT V103M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT L91M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDEN… | monomer | 3×CL; 3×BME; | ||||
Assess | ||||||
N-TERMINAL DOMAIN CORE METHIONINE MUTATION | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
N-TERMINAL DOMAIN CORE METHIONINE MUTATION | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
N-methylaniline in complex with T4 Lysozyme L99A | monomer | 2×PO4; 1×1MR; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--ethylbenzene binding | monomer | 1×PYJ; 2×ACT; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT I78A | monomer | 1×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at 100 MPa | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at 150 MPa | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN… | monomer | 2×CL; 1×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM KRYPTON | monomer | 2×CL; 2×KR; 1×BME; | ||||
Assess | ||||||
T4 Lysozyme Cavity Mutant L99a/M102Q Bound With 2-Allylphenol | monomer | 2×CL; 1×2LP; 2×BME; | ||||
Assess | ||||||
High Pressure Psuedo Wild Type T4 Lysozyme | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT L91A | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at 200 MPa | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at 100 MPa | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAG… | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
High-Pressure T4 Lysozyme | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM KRYPTON | monomer | 2×CL; 4×KR; 2×BME; | ||||
Assess | ||||||
Multiple Methionine Substitutions are Tolerated in T4 Lysozyme and have Coupled Effects on Folding … | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme Cavity Mutant L99A/M102Q Bound with N-Allyl-Aniline | monomer | 2×CL; 3×BME; 1×NYL; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM ARGON | monomer | 2×CL; 2×AR; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT V111M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | monomer | |||||
Assess | ||||||
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at 200 MPa | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT F104M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT V87M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
METHIONINE CORE MUTATION | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | |||||
Assess | ||||||
Crystal structure of phage T4 lysozyme mutant R14A/K16A/I17A/K19A/T21A/E22A/C54T/C97A | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at 100 MPa | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
METHIONINE CORE MUTANT OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--phenol binding | monomer | 1×IPH; 1×CL; 1×CA; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT I78M | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM KRYPTON | monomer | 2×CL; 3×KR; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM XENON | monomer | 2×CL; 2×XE; 1×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at 200 MPa | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM XENON | monomer | 2×CL; 4×XE; 2×BME; | ||||
Assess | ||||||
CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME | monomer | 1×PO4; | ||||
Assess | ||||||
T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--p-xylene binding | monomer | 1×PXY; 1×CL; 1×ACT; | ||||
Assess | ||||||
Crystal structure of spin labeled T4 Lysozyme (T151R1) at 291 K | monomer | 1×MTN; 1×HED; 1×CL; 1×AZI; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM XENON | monomer | 2×CL; 2×XE; 1×BME; | ||||
Assess | ||||||
THERMODYNAMIC AND STRUCTURAL COMPENSATION IN "SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at ambient pressure | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at ambient pressure | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 Lysozyme mutant L99A at ambient pressure | monomer | 2×CL; 2×BME; | ||||
Assess | ||||||
T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM XENON | monomer | 2×CL; 3×XE; 2×BME; | ||||
Assess | ||||||
Long-Distance conformational changes in a protein engineered by modulated sequence duplication | monomer | |||||
Assess | ||||||
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | monomer | 1×CL; 1×HED; | ||||
Assess | ||||||
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | monomer | 1×HED; | ||||
Assess | ||||||
THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
T4 LYSOZYME MUTANT M106K | monomer | 1×CL; | ||||
Assess | ||||||
Protein flexibility and adaptability seen in 25 crystal forms of T4 LYSOZYME | monomer | |||||
Assess | ||||||
STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND … | monomer | |||||
Assess | ||||||
STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND … | monomer | |||||
Assess | ||||||
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE… | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | monomer | |||||
Assess | ||||||
Use of sequence duplication to engineer a ligand-triggered long-distance molecular switch in T4 Lys… | monomer | |||||
Assess | ||||||
Protein flexibility and adaptability seen in 25 crystal forms of T4 LYSOZYME | monomer | 2×CL; | ||||
Assess | ||||||
The structure of T4 Lysozyme I3C/C54T/R125C/E128C complex with Zinc ions | monomer | 1×ZN; | ||||
Assess | ||||||
HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME | monomer | |||||
Assess | ||||||
Sequential reorganization of beta-sheet topology by insertion of a single strand | monomer | 2×SO4; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102Q with Ethylbenzene Bound | monomer | 1×PYJ; | ||||
Assess | ||||||
T4-Lysozyme fusion to Geobacter GGDEF | monomer | 2×GTP; 1×GMP; 1×POP; 1×MG; 1×GOL; 1×ACT; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102Q with Benzene Bound | monomer | 1×BNZ; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102Q with 1-Hydro-2-ethyl-1,2-azaborine Bound | monomer | 1×CL; 1×6OQ; | ||||
Assess | ||||||
Crystal Structure of the Cannabinoid Receptor 1 Interacting Protein 1a (CRIP1a) | monomer | |||||
Assess | ||||||
T4 Lysozyme L99A with 1-Hydro-2-ethyl-1,2-azaborine Bound | monomer | 1×6OQ; 2×CL; | ||||
Assess | ||||||
T4 Lysozyme L99A/M102Q with 1,2-Dihydro-1,2-azaborine Bound | monomer | 1×B20; 2×CL; | ||||
Assess | ||||||
Crystal Structure of mGluR5 in complex with MMPEP at 2.2 A | monomer | 7×OLA; 1×MES; 1×D8B; | ||||
Assess | ||||||
Structure of EspG1 chaperone from the type VII (ESX-1) secretion system determined with the assista… | monomer | 5×CL; | ||||
Assess | ||||||
High resolution crystal structure of human B2-adrenergic G protein-coupled receptor. | monomer | 1×GLC; 6×SO4; 1×CAU; 2×BU1; 1×ACM; 3×CLR; 1×PLM; 1×12P; | ||||
Assess | ||||||
In meso in situ serial X-ray crystallography structure of the Beta2-adrenergic receptor at 100 K | monomer | 1×BGC; 1×CAU; 2×BU1; 1×ACM; 3×CLR; 1×PLM; 1×12P; 6×SO4; | ||||
Assess | ||||||
thermostabilised 7TM domain of human mGlu5 receptor bound to photoswitchable ligand alloswitch-1 | monomer | 1×4YI; | ||||
Assess | ||||||
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in compl… | monomer | 4×OLA; 1×2U8; 1×MES; | ||||
Assess | ||||||
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in compl… | monomer | 4×OLA; 1×51E; | ||||
Assess | ||||||
Crystal Structure of mGluR5 in complex with Fenobam at 2.65 A | monomer | 5×OLA; 1×MES; 1×D7W; 1×OLC; | ||||
Assess | ||||||
The Crystal Structure of human neuropeptide Y Y1 receptor with UR-MK299 | monomer | 1×9AO; | ||||
Assess | ||||||
Structure of beta2 adrenoceptor bound to carazolol and an intracellular allosteric antagonist | monomer | 2×EPE; 2×CLR; 1×8VS; 1×CAU; 1×BU1; 1×ACM; | ||||
Assess | ||||||
Cholesterol bound form of human beta2 adrenergic receptor. | monomer | 1×TIM; 2×CLR; 3×OLC; | ||||
Assess | ||||||
Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists | monomer | 1×73R; 1×VT5; 4×SO4; 1×OLC; 1×ZN; | ||||
Assess | ||||||
Crystal structure of the human beta2 adrenergic receptor in complex with the inverse agonist ICI 11… | monomer | 2×CLR; 1×JRZ; 1×OLA; 2×OLC; 1×PGE; | ||||
Assess | ||||||
Crystal structure of the human beta2 adrenergic receptor in complex with a novel inverse agonist | monomer | 2×CLR; 1×JSZ; 1×OLC; | ||||
Assess | ||||||
Structure of the D2 Dopamine Receptor Bound to the Atypical Antipsychotic Drug Risperidone | monomer | 1×8NU; 3×PEG; 3×OLA; | ||||
Assess | ||||||
Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in compl… | monomer | 4×OLA; 1×MES; 1×51D; | ||||
Assess | ||||||
Crystal structure of the human beta2 adrenergic receptor in complex with the neutral antagonist alp… | monomer | 2×CLR; 1×JTZ; | ||||
Assess | ||||||
beta2AR-T4L - CIM | monomer | 1×BGC; 6×SO4; 1×CAU; 2×BU1; 1×ACM; 3×CLR; 1×PLM; 1×12P; | ||||
Assess | ||||||
Crystal structure of the N-terminal domain of Atg2 | monomer | |||||
Assess | ||||||
Structure of the M3 Muscarinic Acetylcholine Receptor | monomer | 1×0HK; 4×PO4; | ||||
Assess | ||||||
Irreversible Agonist-Beta2 Adrenoceptor Complex | monomer | 1×ERC; 1×CLR; 6×SO4; | ||||
Assess | ||||||
Structure of the M3 muscarinic acetylcholine receptor bound to the antagonist tiotropium crystalliz… | monomer | 1×0HK; | ||||
Assess | ||||||
In meso X-ray crystallography structure of the Beta2-adrenergic receptor at 100 K | monomer | 1×BGC; 1×CAU; 1×BU1; 1×ACM; 3×CLR; 1×PLM; 6×SO4; | ||||
Assess | ||||||
Structure of M1-StaR-T4L in complex with 77-LH-28-1 at 2.17A | monomer | 1×QJT; 8×OLA; 1×PO4; 1×OLC; 1×EPE; 2×PGE; | ||||
Assess | ||||||
GPR40 in complex with partial agonist MK-8666 | monomer | 1×NA; 1×MK6; 1×MLI; 8×OLC; 2×1PE; | ||||
Assess | ||||||
Crystal structure of human protease-activated receptor 1 (PAR1) bound with antagonist vorapaxar at … | monomer | 1×VPX; 9×OLC; 1×CL; 1×NA; | ||||
Assess | ||||||
Crystal structure of PH domain of Osh3 from Saccharomyces cerevisiae | monomer | 5×SO4; | ||||
Assess | ||||||
Structure of M1-StaR-T4L in complex with HTL0009936 at 2.35A | monomer | 1×QK8; 11×OLA; 1×PGE; 3×PO4; | ||||
Assess | ||||||
Crystal structure of Human GPR40 bound to allosteric agonist TAK-875 | monomer | 1×2YB; 5×OLC; 1×1PE; 1×DMS; | ||||
Assess | ||||||
Crystal structure of the PH-like domain of Lam6 | monomer | 1×2PE; | ||||
Assess | ||||||
Complex structure of CSN2 with IP6 | monomer | 1×IHP; 1×SO4; | ||||
Assess | ||||||
Structure of M1-StaR-T4L in complex with GSK1034702 at 2.5A | monomer | 1×QK2; 1×EPE; 6×OLA; 1×PO4; | ||||
Assess | ||||||
Crystal structure of the cholecystokinin receptor CCKAR in complex with devazepide | monomer | 1×1OZ; | ||||
Assess | ||||||
Crystal structure of EP3 receptor bound to misoprostol-FA | monomer | 1×J9P; 4×SO4; 1×OLC; 4×OLA; | ||||
Assess | ||||||
The 2.6 A Crystal Structure of a Human A2A Adenosine Receptor bound to ZM241385. | monomer | 1×ZMA; 5×STE; 7×SO4; | ||||
Assess | ||||||
Agonist bound human A2a adenosine receptor with D52N mutation at 2.60 A resolution | monomer | 1×UKA; 2×OLC; | ||||
Assess | ||||||
Crystal structure of the PE-bound N-terminal domain of Atg2 | monomer | 1×PEE; | ||||
Assess | ||||||
Structure of the human M1 muscarinic acetylcholine receptor bound to antagonist Tiotropium | monomer | 1×0HK; 1×Y01; 3×EDO; 1×PGE; 1×GOL; | ||||
Assess | ||||||
Structure of the human GLP-1 receptor complex with PF-06372222 | monomer | 1×97Y; 2×OLC; 1×OLA; | ||||
Assess | ||||||
Agonist bound structure of the human adenosine A2a receptor | monomer | 1×UKA; 2×OLC; | ||||
Assess | ||||||
The extra-helical binding site of GPR40 and the structural basis for allosteric agonism and increti… | monomer | 1×6XQ; | ||||
Assess | ||||||
Structure of thermal-stabilised(M9) human GLP-1 receptor transmembrane domain | monomer | 1×97Y; 1×OLC; | ||||
Assess | ||||||
Crystal Structure of a Lipid G protein-Coupled Receptor at 2.80A | monomer | 1×ML5; 1×NAG; | ||||
Assess | ||||||
Crystal structure of the cholecystokinin receptor CCKAR in complex with lintitript | monomer | 1×1OE; | ||||
Assess | ||||||
Structure of thermal-stabilised(M8) human GLP-1 receptor transmembrane domain | monomer | 1×97Y; | ||||
Assess | ||||||
Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with … | monomer | 1×8TZ; 1×NA; 1×PO4; | ||||
Assess | ||||||
Structure of the human dopamine D3 receptor in complex with eticlopride | monomer | 1×GLC; 1×ETQ; | ||||
Assess | ||||||
Agonist bound human A2a adenosine receptor with S91A mutation at 2.90 A resolution | monomer | 1×UKA; 1×OLC; | ||||
Assess | ||||||
Crystal structure of human corticotropin-releasing factor receptor 1 (CRF1R) in complex with the an… | monomer | 1×1Q5; 1×OLA; 2×OLC; 1×SO4; | ||||
Assess | ||||||
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist | monomer | 1×QNB; 1×BGC; 2×CL; | ||||
Assess | ||||||
Crystal structure of the cholecystokinin receptor CCKAR in complex with NN9056 | monomer | |||||
Assess | ||||||
Structure of the human GLP-1 receptor complex with NNC0640 | monomer | 1×97V; | ||||
Assess | ||||||
Crystal structure of rhodopsin bound to visual arrestin determined by X-ray free electron laser | monomer | 1×NAG; | ||||
Assess | ||||||
Structure of thermal-stabilised(M6) human GLP-1 receptor transmembrane domain | monomer | 1×97Y; | ||||
Assess | ||||||
Structure of the human histamine H1 receptor in complex with doxepin | monomer | 1×5EH; 1×D7V; 3×PO4; 1×OLC; | ||||
Assess | ||||||
Structure of human beta2 adrenergic receptor bound to constrained epinephrine | monomer | 1×G1I; 1×NA; | ||||
Assess | ||||||
Crystal structure of zebrafish lysophosphatidic acid receptor LPA6 | monomer | 3×OLC; | ||||
Assess | ||||||
Crystal structure of an agonist bound GPCR | monomer | 1×E3R; | ||||
Assess | ||||||
GPR40 in complex with AgoPAM AP8 and partial agonist MK-8666 | monomer | 1×OLC; 1×MK6; 1×7OS; | ||||
Assess | ||||||
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser | monomer | |||||
Assess | ||||||
Crystal Structure of a Lipid G protein-Coupled Receptor at 3.35A | monomer | 1×ML5; 1×NAG; | ||||
Assess | ||||||
Structure of human beta2 adrenergic receptor bound to constrained isoproterenol | monomer | 1×GJ6; 1×NA; | ||||
Assess | ||||||
Structure of the delta opioid receptor bound to naltrindole | monomer | 1×EJ4; | ||||
Assess | ||||||
Crystal structure of the dynein motor domain in the AMPPNP-bound state | monomer | 4×ANP; 1×MG; | ||||
Assess | ||||||
Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with … | monomer | 1×8UN; 1×NA; | ||||
Assess | ||||||
Crystal Structure of human mARC1 | monomer | 1×MTE; 1×EFK; 1×B3P; 4×MOO; 1×PO4; | ||||
Assess | ||||||
Crystal structure of the human glucagon receptor (GCGR) in complex with the antagonist MK-0893 | monomer | 1×5MV; 14×OLA; 1×PE5; 1×TLA; | ||||
Assess | ||||||
The Crystal Structure of Human Neuropeptide Y Y1 Receptor with BMS-193885 | monomer | 1×9AF; | ||||
Assess | ||||||
Circular permutation of Helix A in T4 lysozyme | monomer | |||||
Assess | ||||||
Truncated and mutated T4 lysozyme | monomer | 3×NI; | ||||
Assess | ||||||
Human endothelin receptor type-B in complex with antagonist K-8794 | monomer | 1×K87; 11×OLC; 1×CLR; 5×SO4; | ||||
Assess | ||||||
Human endothelin receptor type-B in the ligand-free form | monomer | 5×SO4; 2×OLC; 1×OLA; | ||||
Assess | ||||||
Structure of the M4 muscarinic acetylcholine receptor (M4-mT4L) bound to tiotropium | monomer | 1×0HK; 3×OLA; 1×EDT; 1×P6G; 3×OLC; | ||||
Assess | ||||||
Crystal structure of the human NK1 substance P receptor | monomer | 1×GBQ; | ||||
Assess | ||||||
Human endothelin receptor type-B in complex with inverse agonist IRL2500 | monomer | 1×D2U; 4×PO4; 8×OLC; | ||||
Assess | ||||||
Crystal structure of the prostaglandin D2 receptor CRTH2 with CAY10471 | monomer | 7×SO4; 1×FT4; 1×MES; 2×OLA; 2×PGE; 4×PGO; 1×PEG; | ||||
Assess | ||||||
Crystal structure of the prostaglandin D2 receptor CRTH2 with fevipiprant | monomer | 1×FSY; 9×SO4; 5×SIN; 1×PGE; 1×OLA; 1×PGO; | ||||
Assess | ||||||
Crystal structure of the human NK1 substance P receptor | monomer | 1×GBQ; 1×OLC; | ||||
Assess | ||||||
Human endothelin receptor type-B in complex with antagonist bosentan | monomer | 1×K86; 4×SO4; | ||||
Assess | ||||||
M3 muscarinic acetylcholine receptor in complex with a selective antagonist | monomer | 1×GLC; 1×PG4; 1×9EC; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1t6h.1.A | monomer | 0.90 | 98.78 | |||
Assess |